Posthatching developmental studies on the tongue and laryngeal entrance of the common quail (Coturnix coturnix, Linnaeus, 1758) in different five age-stages.

The present study represents the first trial to characterize the ultrastructural of five ages of Coturnix coturnix. Lingual nail had membrane that differ in number among five studied ages. Filiform papillary system had four caudally directed papillae types; small (apex, rostral, and median part of body in 1 day, body in 10 and 20 days), long (apex and rostral part of body in 10 days, tip and two lateral area in 20, 30, 40-days, lateral border in 1 and 10 days, two lateral area of body in 40 days), broad (median area of body in 20, 30, 40 days). Scales on the ventral surface of apex, mound. Lingual sulci on the apex and body without reaching tip in 10, 20, 30, 40-days while, in 1 day the body had ridge caudally. Three papillae on posterior part of lateral border of body. W-shape crest had papillae on its median part while, its lateral part had two giant papillae on each side. Dorsal giant papillae terminated caudally with six processes, while ventral papillae terminated caudally with three processes. The unique root appearance, at 1 day had four papillae while in 10-day, it had one papilla however in 20, 30, 40 days, it had T-shaped ridge. Mound had one longitudinal row on each side of cleft and two transverse papillary rows at its caudal border and additional row at 40-days. Our findings exposed unique structural and functional characterizations of lingual and laryngeal entrance that reflected with feeding behavior.

Ameliorative Effect of Graviola (Annona muricata) on Mono Sodium Glutamate-Induced Hepatic Injury in Rats: Antioxidant, Apoptotic, Anti-inflammatory, Lipogenesis Markers, and Histopathological Studies.

Monosodium glutamate (MSG) is a widely used food additive, and there is a trepidation that MSG plays a critical role in multiple hepatic disorders. This study was planned to investigate Graviola extract (GE) effects on hepatic and cellular alterations induced by MSG. Fifty Wistar rats were randomly allocated into five groups: control (received normal saline), Graviola (received 200 mg/kg body weight), MSG (received 2.4 gm MSG/kg, 15% of Lethal dose (LD50) of MSG), Graviola + monosodium glutamate (MSG + GE; received GE, 200 mg/kg/day and MSG 2.4 gm/kg body weight (BW) for the next four weeks), and monosodium glutamate + Graviola (received MSG only (2.4 gm/kg BW) daily for four weeks, then concomitant with Graviola (200 mg/kg BW) daily for the next four weeks. MSG and GR were administered orally for eight weeks. Our results showed that MSG caused a significant increase in oxidative stress markers malondialdehyde (MDA), reactive oxygen species (ROS), nitric oxide (NO), hydrogen peroxide (H2O2), proinflammatory cytokines interleukin 6 (IL-6) level, a tumor protein (P53), hepatic cellular damage, as well as proapoptotic markers caspase-3, and B-cell lymphoma 2 (BCL-2)-like protein 4 (Bax). A significant decrease in superoxide dismutase (SOD), catalase (CAT), glutathione S transferase (GST), reduced glutathione (GSH), and an antiapoptotic agent B-cell lymphoma 2 (BCl-2) was observed. The detected MSG effects were normalized by Graviola administration, either a prophylactic or protecting dose. Besides, Graviola reduced the expression of inducible nitric oxide synthase (iNOS) and hepatic fatty acid synthase (FAS) and led to the upregulation of the silent information regulator protein one gene expression gene (SIRT1).In conclusion, the results suggest that Gaviola's interrelated antiapoptotic, antioxidant, and anti-inflammatory properties are potential mechanisms to enhance hepatic deficits and protect the liver. Graviola can, therefore, be considered a promising hepatoprotective supplement. Additionally, further human clinical trials are also necessary to validate the present research.